Vivanza Biosciences share news, announcements and annual reports
BSE: 530057Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹1.43.
30 Oct: open ₹1.50, high ₹1.60, low ₹1.50
- Next results date: the board meets on 3 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹6.16 Cr4,790th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 13.57
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.41
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 10.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 3.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 2.34
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 24,333
Vivanza Biosciences has 594 announcements on record, routine notices left out; 4 in the 30 days to 1 Nov 2026, the latest on 29 Oct 2026.
Next board meeting and results date
As the company gave notice to the exchange.Vivanza Biosciences quarterly results
The board meets on 3 Nov 2026 to consider quarterly results
Notice filed 28 Oct 2026
Vivanza Biosciences annual reports, presentations and earnings calls
The company's own documents, latest first.Vivanza Biosciences financials, year by year
Annual reports23
- Annual report, year to Mar 202619 Aug 2026
- Annual report, year to Mar 20254 Dec 2025
- Annual report, year to Mar 20249 Jul 2024
- Annual report, year to Mar 20231 Jul 2023
- Annual report, year to Mar 202229 Jun 2022
18 earlier reports
- Annual report, year to Mar 202116 Sep 2021
- Annual report, year to Mar 202016 Sep 2020
- Annual report, year to Mar 20197 Sep 2019
- Annual report, year to Mar 20182 Oct 2018
- Annual report, year to Mar 20173 Oct 2017
- Annual report, year to Mar 201619 Oct 2016
- Annual report, year to Mar 20158 Sep 2015
- Annual report, year to Mar 201411 Sep 2014
- Annual report, year to Mar 201324 Sep 2013
- Annual report, year to Mar 201218 Dec 2012
- Annual report, year to Mar 20108 Nov 2011
- Annual report, year to Mar 201115 Sep 2011
- Annual report, year to Mar 2009Filing day not known
- Annual report, year to Mar 2008Filing day not known
- Annual report, year to Mar 2002Filing day not known
- Annual report, year to Mar 2000Filing day not known
- Annual report, year to Mar 1999Filing day not known
- Annual report, year to Mar 1998Filing day not known
Vivanza Biosciences share news and announcements
Newest first. Page 1 of 12.
Oct 2026
29 Oct · Non-Applicability Of Regulation 23(9) Of SEBI (LODR) Regulations, 2015 Regarding Submission Of Disclosures Of Related Party Transactions For The Half Year Ended On September 30, 2026
28 Oct · Board meeting
Meeting on 3 Nov 2026: quarterly results
Sep 2026
12 Sep · Meeting
Aug 2026
12 Aug · Board meeting
Meeting on 17 Aug 2026: annual general meeting7 Aug · Outcome Of Board Of Directors Meeting Of Vivanza Biosciences Limited ('The Company')
Jul 2026
28 Jul · Board meeting
Meeting on 7 Aug 2026: quarterly results14 Jul · Declaration Pursuant To Regulation 33(3)(D) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Jun 2026
15 Jun · Board meeting
Meeting on 18 Jun 2026
May 2026
7 May · Non Applicability Of Related Party Transaction Under Regulation 23(9) Of SEBI (LODR) Regulations, 2015 For The Quarter And Year Ended 31St March, 2026
4 May · Board meeting
Meeting on 7 May 2026: audited results
Apr 2026
28 Apr · Board meeting
Meeting on 4 May 2026: audited resultsNot held on this date
14 Apr · Business
Mar 2026
Feb 2026
5 Feb · Board meeting
Meeting on 12 Feb 2026: quarterly results
Dec 2025
18 Dec · Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
17 Dec · Meeting
17 Dec · Meeting
Nov 2025
11 Nov · Non-Applicability Of Disclosure Under Regulation 23(9) Of SEBI (LODR) Regulations, 2015 For The Quarter And Half Year Ended On 30Th September, 2025
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.
- 18 Jun 2026Board or managers changeddown 4.84%−5.3 pts vs Nifty 500market median 0.0% · five sessions +7.5% (+7.5 pts vs Nifty 500) · volume 1.0× usual · The announcement
- 4 May 2026Board or managers changeddown 3.38%−4.0 pts vs Nifty 500market median 0.0% · five sessions −8.2% (−10.1 pts vs Nifty 500) · volume 1.8× usual · The announcement
- 17 Mar 2026Board or managers changed0.00%−0.8 pts vs Nifty 500market median 0.0% · five sessions −4.2% (−0.3 pts vs Nifty 500) · volume 2.0× usual · The announcement
- 29 Sep 2025Board or managers changedup 0.49%+0.4 pts vs Nifty 500market median 0.0% · five sessions 0.0% (−2.0 pts vs Nifty 500) · volume 1.8× usual · The announcement
- 1 Sep 2025Board or managers changedup 1.46%+0.3 pts vs Nifty 500market median 0.0% · five sessions 0.0% (−1.6 pts vs Nifty 500) · volume 2.0× usual · The announcement
- 13 May 2025Board or managers changeddown 0.94%−0.2 pts vs Nifty 500market median 0.0% · five sessions +19.8% (+18.2 pts vs Nifty 500) · volume 1.4× usual · The announcement
- 12 Mar 2025Board or managers changeddown 1.79%−1.6 pts vs Nifty 500market median 0.0% · five sessions −5.4% (−8.1 pts vs Nifty 500) · volume 0.4× usual · The announcement
- 31 Jan 2025Board or managers changedup 1.34%0.0 pts vs Nifty 500market median 0.0% · five sessions −13.1% (−15.4 pts vs Nifty 500) · volume 0.2× usual · The announcement
- 12 Jun 2024Board or managers changeddown 1.15%−1.7 pts vs Nifty 500market median 0.0% · five sessions −3.0% (−4.7 pts vs Nifty 500) · volume 1.6× usual · The announcement
- 20 Jan 2023Order receiveddown 0.70%−0.2 pts vs Nifty 500market median +1.1% · five sessions −6.6% (−3.1 pts vs Nifty 500) · volume 9.5× usual · The announcement
3 earlier announcements
- 12 Oct 2020Board or managers changed–market median 0.0% · five sessions +26.9% (+23.7 pts vs Nifty 500) · volume 0.2× usual · The announcement
- 16 Apr 2019Board or managers changed–market median 0.0% · volume 0.5× usual · The announcement
- 8 May 2018Board or managers changed–market median 0.0% · volume 0.3× usual · The announcement